Virbac group
Virbac Group, a leading player in the global animal health industry, is headquartered in France and operates extensively across Europe, North America, and Asia. Founded in 1964, the company has established itself as a trusted provider of veterinary products and services, focusing on the health and well-being of companion animals and livestock. Virbac's core offerings include vaccines, pharmaceuticals, and nutritional products, all designed to enhance animal health and productivity. What sets Virbac apart is its commitment to research and development, ensuring innovative solutions tailored to the evolving needs of veterinarians and pet owners alike. With a strong market position, Virbac has achieved notable milestones, including a robust international presence and a diverse product portfolio that reflects its dedication to quality and efficacy in animal care.
DitchCarbon Score
How does Virbac group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Virbac group's score of 31 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Virbac group's reported carbon emissions
In 2022, Virbac Group reported carbon emissions of approximately 23,727,000 kg CO2e, all of which fall under Scope 1 emissions. This represents an increase from 20,814,000 kg CO2e in 2021 and 21,007,000 kg CO2e in 2020. The company has not disclosed any Scope 2 or Scope 3 emissions data for these years. Virbac's emissions data is sourced directly from Virbac SA, with no cascaded data from a parent or related organization. The company has not set specific reduction targets or initiatives as part of its climate commitments, indicating a potential area for future development in sustainability practices. The GHG intensity for all scopes, as reported, is approximately 0.237 kg CO2e per unit of revenue in 2022, reflecting the company's emissions relative to its financial performance. As Virbac continues to operate in the veterinary pharmaceutical industry, addressing its carbon footprint will be crucial for aligning with global climate goals and enhancing its sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2014 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 19,186,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 15,014,000 | - | - | - |
| Scope 3 | 6,818,000 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Virbac group is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
